Several considerations in using traditional Chinese patent medicine for cerebral infarction

Jia He; Yihyun Kwon; Chao Li; Xue-qi Zhang; Jian-guo Zhao

doi:10.1007/s11655-012-1186-8

Your Location：

Home >

Browse articles >

Several considerations in using traditional Chinese patent medicine for cerebral infarction

Updated：2021-08-27

- Several considerations in using traditional Chinese patent medicine for cerebral infarction
- Chinese Journal of Integrative Medicine Vol. 18, Issue 8, Pages: 571-574(2012)
- Affiliations：
  
  1. Tianjin University of Traditional Chinese Medicine,Tianjin,China
  2. National University of Health Sciences, Lombard,USA
  3. Department of Neurology of Integrated Traditional Chinese and Western Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-012-1186-8
  CLC：
- Published：2012，
  
  Published Online：2 August 2012，
Scan for full text
He, J., Kwon, Y., Li, C. et al. Several considerations in using traditional Chinese patent medicine for cerebral infarction., Chin. J. Integr. Med. 18, 571–574 (2012). https://doi.org/10.1007/s11655-012-1186-8

Jia He, Yihyun Kwon, Chao Li, et al. Several considerations in using traditional Chinese patent medicine for cerebral infarction. [J]. Chinese Journal of Integrative Medicine 18(8):571-574(2012)
He, J., Kwon, Y., Li, C. et al. Several considerations in using traditional Chinese patent medicine for cerebral infarction., Chin. J. Integr. Med. 18, 571–574 (2012). https://doi.org/10.1007/s11655-012-1186-8 DOI：

Jia He, Yihyun Kwon, Chao Li, et al. Several considerations in using traditional Chinese patent medicine for cerebral infarction. [J]. Chinese Journal of Integrative Medicine 18(8):571-574(2012) DOI： 10.1007/s11655-012-1186-8.

摘要

Nowadays

a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China. When great attention is paid to using TCPM in the real world

several problems can be identified: ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation

a lack of appropriate dosage and usage based on individual patient conditions

and a shortage of evidence from randomized

double-blind

placebo-controlled clinical trials. Furthermore

in terms of evaluation of the TCPM effectiveness

few comprehensive criteria and evaluation methods recognized by the international community exist. This article addresses some opinions regarding the above mentioned problems. Prof. ZHAO Jian-guo

Abstract

Nowadays

a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China. When great attention is paid to using TCPM in the real world

several problems can be identified: ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation

a lack of appropriate dosage and usage based on individual patient conditions

and a shortage of evidence from randomized

double-blind

placebo-controlled clinical trials. Furthermore

in terms of evaluation of the TCPM effectiveness

few comprehensive criteria and evaluation methods recognized by the international community exist. This article addresses some opinions regarding the above mentioned problems. Prof. ZHAO Jian-guo

关键词

Cerebral Infarctionischemic stroketraditional Chinese patent medicine

Keywords

Cerebral Infarctionischemic stroketraditional Chinese patent medicine

references

Zhao M, Li JS, Zhang BL. The present situation of exploitation and application of Chinese patent medicine in stroke. J Emerg Tradit Chin Med (Chin) 2005;14:1216–1217.

Hou TZ. The discussion of treating stroke by TCPM based on syndrome differentiation. Lishizhen Med Mater Med Res (Chin) 2001;12:727.

Liu JP. Evidence-based medicine and individualized health care. J Chin Integr Med (Chin) 2009;7:505–508.

Luo YF, Sun YH. On the development of syndrome in traditional Chinese medicine. J Inf Tradit Chin Med (Chin) 2005;22(6):3–4.

Cai BG. The rational medication of Chinese medicine injection in ischemic stroke. J Tradit Chin Med (Chin) 2010;51:126–127.

Wang YY, Zhang BL, eds. The subject of encephalopathy in traditional Chinese medicine. 1st ed. Beijing: People’s Medical Publishing House;2007:660.

Zhang H. Discussion of rational medication of TCPM and standardized administration. Guid J Tradit Chin Med Pharm (Chin) 2009;15(10):65–66.

Xia DS, Zhang L. Analysis of rational medication of TCPM with toxicity and prevention of untoward effect. Chin J Hosp Pharm (Chin) 2010;30:2120–2122.

Xie H, Zhu LF. On safety risk factors of Chinese patent medicine. China Pharm (Chin) 2011;22:1436–1438.

Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775–1776.

Matthews MK Jr. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998;50:1933–1994.

Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998;352:36.

Zhang W, Lin XL. The rational medication in stroke by TCPM. Chin J Inf Tradit Chin Med (Chin) 2006;13(10):108–109.

Jiang JJ, Xie YM. Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics. China J Chin Mater Med (Chin) 2011;36:2811–2812.

Wu B, Liu M, Liu H, Li W, Tan S, Zhang SH, et al. Metaanalysis of traditional Chinese patent medicine for ischemic stroke. Stroke 2007;38:1973–1979.

Feigin VL. Herbal medicine in stroke-Does it have a future? Stroke 2007;38:1734–1736.

Li T. Some problems in inclusion criteria and evaluation indexes of clinical trials in traditional herbs medicine for patients with cerebral infarction. Chin J Clin Pharm Ther (Chin) 2005;12:1430–1433.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

A pilot study on the correlation of tongue manifestation with the site of cerebral infarction in patients with stroke

Exploring molecular mechanism underlying Chinese medicine syndrome: A study on correlation between Chinese medicine syndrome and biomarkers for ischemic stroke

The use of repeated measures analysis of variance to study the effect of phlegm-heat syndrome on neurological deficits in patients with stroke

Evaluation of the conjoint efficacy in Chinese medicine with the longitudinal latent variable linear mixed model

Related Author

No data

Related Institution

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center

School of Public Health, Peking University Health Science Center, Peking University

Neurology Department of Peking University First Hospital, Peking University

Neurology Department of Peking University Third Hospital, Peking University

Department of Hospital Management, Peking University Health Science Center, Peking University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰